90 related articles for article (PubMed ID: 32674732)
1. Ligand and Structure-based Virtual Screening of Lamiaceae Diterpenes with Potential Activity against a Novel Coronavirus (2019-nCoV).
Rodrigues GCS; Dos Santos Maia M; de Menezes RPB; Cavalcanti ABS; de Sousa NF; de Moura ÉP; Monteiro AFM; Scotti L; Scotti MT
Curr Top Med Chem; 2020; 20(24):2126-2145. PubMed ID: 32674732
[TBL] [Abstract][Full Text] [Related]
2. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
[TBL] [Abstract][Full Text] [Related]
3. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.
Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A
Molecules; 2020 May; 25(11):. PubMed ID: 32485894
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatic study to discover natural molecules with activity against COVID-19.
Singh S; Florez H
F1000Res; 2020; 9():1203. PubMed ID: 33145015
[No Abstract] [Full Text] [Related]
5. Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov.
Zhang H; Saravanan KM; Yang Y; Hossain MT; Li J; Ren X; Pan Y; Wei Y
Interdiscip Sci; 2020 Sep; 12(3):368-376. PubMed ID: 32488835
[TBL] [Abstract][Full Text] [Related]
6. Establishment and validation of a drug-target microarray for SARS-CoV-2.
Chen P; Zeng Z; Du H
Biochem Biophys Res Commun; 2020 Sep; 530(1):4-9. PubMed ID: 32828312
[TBL] [Abstract][Full Text] [Related]
7. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.
Vivek-Ananth RP; Rana A; Rajan N; Biswal HS; Samal A
Molecules; 2020 Aug; 25(17):. PubMed ID: 32842606
[TBL] [Abstract][Full Text] [Related]
8. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach.
Aftab SO; Ghouri MZ; Masood MU; Haider Z; Khan Z; Ahmad A; Munawar N
J Transl Med; 2020 Jul; 18(1):275. PubMed ID: 32635935
[TBL] [Abstract][Full Text] [Related]
9. Alkamides and Piperamides as Potential Antivirals against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Gutierrez-Villagomez JM; Campos-García T; Molina-Torres J; López MG; Vázquez-Martínez J
J Phys Chem Lett; 2020 Oct; 11(19):8008-8016. PubMed ID: 32840378
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0.
Gervasoni S; Vistoli G; Talarico C; Manelfi C; Beccari AR; Studer G; Tauriello G; Waterhouse AM; Schwede T; Pedretti A
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708196
[TBL] [Abstract][Full Text] [Related]
11. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
12. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data.
Chakraborti S; Bheemireddy S; Srinivasan N
Mol Omics; 2020 Oct; 16(5):474-491. PubMed ID: 32696772
[TBL] [Abstract][Full Text] [Related]
13. In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking.
Joshi T; Joshi T; Sharma P; Mathpal S; Pundir H; Bhatt V; Chandra S
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4529-4536. PubMed ID: 32373991
[TBL] [Abstract][Full Text] [Related]
14. Putative SARS-CoV-2 M
Mazzini S; Musso L; Dallavalle S; Artali R
Molecules; 2020 Aug; 25(16):. PubMed ID: 32824454
[TBL] [Abstract][Full Text] [Related]
15. Optimization Rules for SARS-CoV-2 M
Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
[TBL] [Abstract][Full Text] [Related]
16. The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options.
Asghari A; Naseri M; Safari H; Saboory E; Parsamanesh N
DNA Cell Biol; 2020 Oct; 39(10):1741-1753. PubMed ID: 32716648
[TBL] [Abstract][Full Text] [Related]
17. Structural Biology Aids the Research of New Anti-COVID-19 Drugs.
Lu J; Liu X
Curr Org Synth; 2020; 17(3):162-163. PubMed ID: 32538717
[No Abstract] [Full Text] [Related]
18. Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19.
Hage-Melim LIDS; Federico LB; de Oliveira NKS; Francisco VCC; Correia LC; de Lima HB; Gomes SQ; Barcelos MP; Francischini IAG; da Silva CHTP
Life Sci; 2020 Sep; 256():117963. PubMed ID: 32535080
[TBL] [Abstract][Full Text] [Related]
19. Novel Binding Mechanisms of Fusion Broad Range Anti-Infective Protein Ricin A Chain Mutant-Pokeweed Antiviral Protein 1 (RTAM-PAP1) against SARS-CoV-2 Key Proteins in Silico.
Hassan Y; Ogg S; Ge H
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32957454
[TBL] [Abstract][Full Text] [Related]
20. Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2.
Sharma K; Morla S; Goyal A; Kumar S
Life Sci; 2020 Oct; 259():118169. PubMed ID: 32738360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]